About 267,000 results
Open links in new tab
  2. People also ask
    Who is Ascendis Pharma?
    Ascendis Pharma (ASND) Company Description: Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. Through its TransCon technology, it develops a pipeline of sustained release prodrug therapies including endocrinology product candidates to support the market.

    Ascendis Pharma’s Strategic Partnership with Novo Nordisk: A Promisin…

    markets.businessinsider.com
    Is Ascendis Pharma partnering with Novo Nordisk?
    Ascendis Pharma (ASND) has released an update. Ascendis Pharma has entered a collaboration with Novo Nordisk to license its TransCon technology, aiming to develop treatments for metabolic and cardiovascular diseases, including a monthly TransCon Semaglutide product for obesity and type 2 diabetes.

    Ascendis Pharma and Novo Nordisk Join Forces

    finance.yahoo.com
    Does Ascendis have a supplemental biologics licence?
    Ascendis gained US Food and Drug Administration (FDA) approval for its TransCon-based hypoparathyroidism drug Yorpvipath (palopegteriparatide) in August 2024. In October, the company submitted a supplemental biologics licence application (sBLA) for TransCon hGH, marketed as Skytrofa, to treat growth hormone deficiency.

    Novo Nordisk signs $285m deal with Ascendis to create once-monthly …

    msn.com
    Does Ascendis have a Transcon license?
    Ascendis will grant an exclusive, worldwide license for its TransCon technology to Novo Nordisk to develop, manufacture, and commercialise metabolic disease products and product-by-product licenses for those in cardiovascular indications.

    Novo Nordisk signs $285m deal with Ascendis to create once-monthly …

    msn.com
    Feedback
  3. Markets Insider
    https://markets.businessinsider.com/news/stocks/...

    Ascendis Pharma Expands Capital to Fuel Growth - Markets Insider

    See results only from markets.businessinsider.com
  4. Ascendis Pharma
    https://investors.ascendispharma.com/news-releases-us

    News Releases - Ascendis Pharma

  5. Yahoo Finance
    https://finance.yahoo.com/news/ascendis-pharma...

    Ascendis Pharma and Novo Nordisk Join Forces - Yahoo Finance

  6. Yahoo Finance
    https://finance.yahoo.com/news/ascendis-pharma...

    Ascendis Pharma Presents New Data and Updated Results from …

  7. Nasdaq
    https://www.nasdaq.com/press-release/ascendis...

    Ascendis Pharma to Report Third Quarter 2024 Financial Results

  8. Ascendis Pharma
    https://investors.ascendispharma.com/news-releases/...

    Ascendis Pharma Announces Submission of Supplemental …

  9. Markets Insider
    https://markets.businessinsider.com/news/stocks/...

    Ascendis Pharma Receives Buy Rating Amid Positive Phase 3 …

  10. Investor's Business Daily
    https://www.investors.com/news/technology/ascendis...

    Ascendis Pharma Zooms Closer To A Breakout After FDA Approves ...

  11. BioSpace
    https://www.biospace.com/press-relea…

    Ascendis Pharma to Report Third Quarter 2024 …

    6 days ago · The link to the live webcast will also be available on the Investors & News section of the Ascendis Pharma website at https://investors.ascendispharma.com. A replay of the webcast will be …

  12. Investor's Business Daily
    https://www.investors.com/news/technology/ascendis...

    Ascendis Pharma Skyrockets As It Looks To Take On BioMarin's …

  14. Some results have been removed